Wall Street Analysts Think LifeStance Health (LFST) Could Surge 45.04%: Read This Before Placing a Bet

Group 1 - LifeStance Health Group (LFST) closed at $5.95, with an 8% gain over the past four weeks, and a mean price target of $8.63 indicates a 45% upside potential [1] - The average price targets from analysts range from $7 to $10, with a standard deviation of $1.03, suggesting a variability in estimates; the lowest estimate indicates a 17.7% increase, while the highest points to a 68.1% upside [2] - Analysts show strong agreement on LFST's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for LFST has increased by 43.6% due to four upward revisions in earnings estimates over the last 30 days, with no negative revisions [12] - LFST holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] - While price targets may not be reliable indicators of the extent of gains, they can provide a directional guide for price movement [10][13]